Mission, Vision and Values

Mission

Our mission is to unleash the transformative power of medical nutrition to help resolve chronic health conditions that cannot be resolved by drugs alone.


Vision

Our vision is to be recognised as the leader in Medical Nutrition throughout Asia Pacific and use our position to positively impact the lives of people in our region.


Values

We seek to demonstrate our core values in all that we do

Credible
Credibility is our most fundamental value, stemming from our desire to be a trusted partner in people’s healthcare journey. This is achieved through a spirit of collaboration, integrity, loyalty and accountability. We accept agreements as binding, we promise only what we can deliver, and we respect and observe the law in all our business transactions. 

Ethical
Maintaining the highest ethical standards is an essential component of the Grünbiotics DNA. This is our promise to everyone we interact with, and we insist that our partners and suppliers share this commitment. We believe in mutual respect, and we employ open, honest and ethical behaviour in all our interactions with customers, clients, colleagues, suppliers, and partners.

Caring
We are driven by our commitment to improve the quality of life of those suffering from medical disorders in our communities. We genuinely care about the positive impact our products have on users and their families, and we are continually looking to improve upon this. 

Innovative
Innovation is the key to improving health outcomes and fueling our plans for the future. We embrace creativity and constantly pursue new opportunities. We continually strive to make our products more beneficial for our consumers and find new and better Medical Nutrition products.

Science-based
Scientific research and technical expertise form the backbone of what we do now, and what we plan to do in the future. Our products are developed using an evidence-based approach to Medical Nutrition, and are designed to either support existing pharmaceutical therapies or provide options for monotherapies.